Literature DB >> 23621556

How to manage patients with gout.

T Bardin1, G Desideri.   

Abstract

OBJECTIVES: Recently, after almost 50 years of dormancy, new therapeutic agents for the management of gout have entered the market or are in clinical development. In this article, the current guidelines for the diagnosis and management of gout are reviewed.
METHODS: Key papers for inclusion were identified by a PubMed search, and articles were selected according to their relevance for the topic, according to the authors' judgment. RESULTS AND
CONCLUSIONS: Although our therapeutic arsenal is strong, and effective gout management with urate lowering therapy improves many patient-reported outcomes in clinical trials, major gaps exist in patient understanding of disease and adherence to long-term therapy. Research is required to identify the optimal models of care for patients with gout. However, quality of care in gout can be enhanced through better gout-centered education. To properly manage gout, education of the gout patient is critical, since only the patient who understands their gout will stay with their medication long-term.

Entities:  

Mesh:

Year:  2013        PMID: 23621556     DOI: 10.1185/03007995.2013.790802

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN: 0300-7995            Impact factor:   2.580


  3 in total

Review 1.  Therapeutic approaches to chronic hyperuricemia and gout.

Authors:  Davide Grassi; Roberto Pontremoli; Raffaella Bocale; Claudio Ferri; Giovambattista Desideri
Journal:  High Blood Press Cardiovasc Prev       Date:  2014-04-03

2.  Urate lowering therapy with febuxostat in daily practice-a multicentre, open-label, prospective observational study.

Authors:  Anne-Kathrin Tausche; Monika Reuss-Borst; Ute Koch
Journal:  Int J Rheumatol       Date:  2014-09-03

3.  Primary Prevention of Cardiovascular Risk in Octogenarians by Risk Factors Control.

Authors:  Pasquale Palmiero; Annapaola Zito; Maria Maiello; Annagrazia Cecere; Anna Vittoria Mattioli; Roberto Pedrinelli; Pietro Scicchitano; Marco Matteo Ciccone
Journal:  Curr Hypertens Rev       Date:  2019
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.